Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Walsh

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patientsMichael D Walsh, Margaret C Cummings, Daniel D Buchanan, et al.
European Journal of Human Genetics : EJHG|November 30, 2006
Stability of BAT26 in Lynch syndrome colorectal tumoursLesley Jaskowski, Joanne Young, Leigh Jackson, et al.
Familial Cancer|January 5, 2013
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?Mark Clendenning, Michael D Walsh, Judith Balmana Gelpi, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gastroenterology|November 15, 2006
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopyKevin J Spring, Zhen Zhen Zhao, Rozemary Karamatic, et al.
Plos One|June 21, 2013
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survivalChristophe Rosty, Joanne P Young, Michael D Walsh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotypeDallas R English, Joanne P Young, Julie A Simpson, et al.
Epigenetics|June 28, 2013
Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancerRhiannon J Walters, Elizabeth J Williamson, Dallas R English, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregationSharlene Gill, Noralane M Lindor, Lawrence J Burgart, et al.
International Journal of Epidemiology|April 26, 2012
Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysisLaura A E Hughes, Elizabeth J Williamson, Manon van Engeland, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patientsMichael D Walsh, Margaret C Cummings, Daniel D Buchanan, et al.
European Journal of Human Genetics : EJHG|November 30, 2006
Stability of BAT26 in Lynch syndrome colorectal tumoursLesley Jaskowski, Joanne Young, Leigh Jackson, et al.
Familial Cancer|January 5, 2013
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?Mark Clendenning, Michael D Walsh, Judith Balmana Gelpi, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gastroenterology|November 15, 2006
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopyKevin J Spring, Zhen Zhen Zhao, Rozemary Karamatic, et al.
Plos One|June 21, 2013
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survivalChristophe Rosty, Joanne P Young, Michael D Walsh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotypeDallas R English, Joanne P Young, Julie A Simpson, et al.
Epigenetics|June 28, 2013
Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancerRhiannon J Walters, Elizabeth J Williamson, Dallas R English, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregationSharlene Gill, Noralane M Lindor, Lawrence J Burgart, et al.
International Journal of Epidemiology|April 26, 2012
Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysisLaura A E Hughes, Elizabeth J Williamson, Manon van Engeland, et al.
Pageof 7